Imaging
Sale of imaging device to U.K. Christie Hospital to treat skin cancer announced
Published in Medical Letter on the CDC and FDA, July 17th, 2005
This marks the first sale of the Episcan I-200 for use in conjunction with photodynamic therapy (PDT) for the treatment of basal cell carcinoma, a type of skin cancer, and Bowen's disease, a common pre-malignant condition of the skin, and opens a new market for Longport. The purchase of the Episcan I-200 by a hospital within the British National Health System also is expected to provide a greater profile for Longport in the U.K.
The purchase is for routine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Air Pollution
Cardiorespiratory hospitalizations linked to forest fire smoke exposure - Diarrheal Disease
Developing bacterial vaccines to prevent diarrheal diseases reviewed - Food-Borne Illness
Food service workers' self-reported food preparation practices listed - Meningococcal Vaccine
Cost-effectiveness of meningococcal vaccine strategies in U.S. examined - Myelodysplastic Syndrome
Azacitidine approved for treatment of myelodysplastic syndrome - Acne
Company receives FDA nonapprovable letter for Velac - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
